Patent classifications
C07F7/0807
ORGANIC COMPOUND AND APPLICATION THEREOF
Provided are an organic compound and an application thereof. The organic compound has a structure as shown in Formula I. The overlap degree between HOMO and LUMO is effectively reduced through structural framework design and specific group introduction, thus the energy level difference between the triplet state and the singlet state is reduced to below 300 meV, the reverse crossing of the energy from the triplet to the singlet is satisfied. The organic compound obtains a relatively balanced radiative transition rate and good TADF characteristics, and has excellent carrier transport performance, balance and stability of electron mobility and hole mobility, low preparation cost, and environmental friendliness. The organic compound can be used as a light-emitting layer material of an OLED device, and the material has a TADF light-emitting mechanism and high light-emitting quantum efficiency, which can reduce the drive voltage and energy consumption, and improve luminous efficiency and working life.
ADHESIVE COMPOSITION, COVERING SUBSTRATE, AND CURED PRODUCT
The adhesive composition includes: a cyclic organosilazane compound of the following general formula (1):
##STR00001##
wherein R.sup.1s each independently represent a substituted or unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms, and p represents an integer of 3 to 8; and a hydrolyzable group-containing organosilicon compound containing an alkoxysilane
compound of the following general formula (2) and/or a partial hydrolytic condensate thereof:
R.sup.2.sub.x—Si(OR.sup.3).sub.4-x (2)
wherein R.sup.2 represents an unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms and optionally having an oxygen atom, R.sup.3 represents an unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms, and x represents an integer of 0 to 2.
3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors
The present invention is directed to substituted 5-trifluoromethyl oxadiazole compounds of generic formula (I) or a pharmaceutically acceptable salt thereof. In particular, the invention is directed to a class of aryl and heteroaryl substituted 5-trifluoromethyl oxadiazole compounds of formula I which may be useful as HDAC6 inhibitors for treating cellular proliferative diseases, including cancer, neurodegenerative diseases, such as schizophrenia and stroke, as well as other diseases. ##STR00001##
COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE
A composition for an organic photoelectronic device, an organic photoelectronic device, and a display device, the composition comprising a first compound represented by Chemical Formula 1, and a second compound represented by Chemical Formula 2:
##STR00001##
Organic electroluminescent materials and devices
The present invention relates to compounds containing fused dibenzo more-than-six-membered heterocycles or azaheterocycles. These compounds may be useful as host materials for phosphorescent electroluminescent devices.
Triphenylene-based materials for organic electroluminescent devices
The present invention relates to compounds of the formula (1) and (2) which are suitable for use in electro¬nic devices, in particular organic electroluminescent devices.
HETEROAROMATIC COMPOUNDS
The present application concerns silafluorene derivatives according to a specific formula. The silafluorene derivatives can be employed in electronic devices. Furthermore, the present application concerns methods for preparation of the silafluorene derivatives, and electronic devices comprising the silafluorene derivatives.
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR
This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis by administering such modulators and pharmaceutical compositions, and processes for making such modulators.
DIBENZOHETEROCYCLIC COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF
A dibenzoheterocyclic compound wherein band gaps of HOMO and LUMO energy levels of the dibenzoheterocyclic compound are wide, light can be emitted in a deep blue light-emitting region; and the LUMO energy level of the dibenzoheterocyclic compound is low, so the LUMO energy level matches with an electron transport layer for electrons injection and transport. The dibenzoheterocyclic compound has hole transport performance, so as a light-emitting layer material, the dibenzoheterocyclic compound balances the ratio of electrons to holes in a light-emitting layer increasing the combination probability and improving the device light-emitting efficiency. The spatial configuration of the dibenzoheterocyclic compound avoids material stacking molecules, reduces annihilation of excitons, and inhibits efficiency roll-off. The dibenzoheterocyclic compound has thermal stability, so deep blue light can be emitted efficiently and stably. With an organic light-emitting diode and a deep blue light-emitting device with high light-emitting efficiency, low working voltage can be obtained.
SOLAR CELL
A composition for solar cell electrodes, an electrode formed of the same, and a method of forming an electrode, the composition including a conductive powder; a glass frit; at least one of a cyclosiloxane compound and a silsesquioxane compound; and an organic vehicle.